Underuse of Parkinson's device questioned in Germany
This article was originally published in Clinica
Executive Summary
Germany lags behind the majority of western European countries in providing patients suffering from Parkinson's disease with pioneering therapy in the form of a deep brain stimulation device (see Clinica No 1002, p 23), claims the European Parkinson's Disease Association (EPDA). Medtronic's Activa Parkinson's Control Therapy device could be used to treat an estimated 20% of sufferers, it says, but it is used on only 5.2% of patients in Germany.
You may also be interested in...
‘Clear’ Is In The Eye Of The Beholder, New York, CRN Argue In Age-Restricted Sales Litigation
CRN’s request for clarification, as it continues litigating complaint in US District Court for Southern New York, highlights what it contends is vague and overly general language in the legislation passed in October with a 22 April effective date.
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.